Novartis AG is 220.8x more valuable than MoonLake Immunotherapeutics by market capitalization ($283.13 B vs $1.28 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MLTX | NVS |
|---|---|---|
| Market cap | $1.28 B | $283.13 B |
| US-listed rank | #2452 | #47 |
| Net income (latest FY) | -$227.32M | - |
| SEC filings | 296 | 947 |
Novartis AG is 220.8x more valuable than MoonLake Immunotherapeutics by market capitalization ($283.13 B vs $1.28 B).
Full pages: MoonLake Immunotherapeutics and Novartis AG, or browse the full rankings.